The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Highlights•Doxorubicin (DOX) is considered one of the most effective chemotherapeutic
agents.•Dose-cumulative cardiotoxicity is the most dangerous adverse effect.•DOX-based …

Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC)
cases. We performed a review and meta-analysis to evaluate survival after resection of CRC …

Summary Background Data: Multiple series have reported on the safety and efficacy of
laparoscopic liver surgery. Small and medium sized procedures have become …

An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …

Background Radiofrequency ablation (RFA) and microwave ablation (MWA) are widely
accepted techniques to eliminate small unresectable colorectal liver metastases (CRLM) …

Objective (s): To investigate rates and patterns of recurrence in patients following curative
intent surgery for colorectal liver metastasis. Background: Outcomes following surgical …

Objective: To identify risk factors associated with cancer-specific survival and develop a
predictive model for patients undergoing primary hepatic resection for metastatic colorectal …

Purpose To evaluate the efficacy and tolerability of high-dose stereotactic body radiation
therapy (SBRT) for the treatment of patients with one to three hepatic metastases. Patients …

Purpose To assess safety and outcome of radiofrequency ablation (RFA) and microwave
ablation (MWA) as compared to systemic chemotherapy and partial hepatectomy (PH) in the …